Among adults 65 years and older, vaccine effectiveness was 54% in the first 7 to 59 days.
Monovalent XBB.1.5 vaccine shows 51% protection against COVID hospitalization
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows